GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Core EBITDA Growth(%) | -6.52 | - |
What is the latest Core EBITDA Growth ratio of GUFIC BIOSCIENCES ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | -6.52 |
| Mar2024 | - |
How is Core EBITDA Growth of GUFIC BIOSCIENCES Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | -6.52 | 0 | |
| Mar2024 | 0 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹3,315.4 Cr | 0.9% | -9.6% | -32.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,529.0 Cr | 2.7% | 3.7% | -6.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,067.0 Cr | -5.3% | 0.6% | 10% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,376.0 Cr | 7.5% | 8.1% | 19.2% | Stock Analytics | |
| CIPLA | ₹122,773.0 Cr | 1.3% | -2.7% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,595.0 Cr | 2% | -2.8% | -7% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 0.9% |
-9.6% |
-32.3% |
| SENSEX | 1.2% |
2.8% |
6.3% |
You may also like the below Video Courses